v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Net loss $ (12,987) $ (4,175)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 274 475
Amortization of identified intangible assets 1,073 1,129
Amortization of deferred loan origination costs 27 36
Amortization of deferred sales commissions 740 397
Non-cash lease expense 453 377
Stock-based compensation expense 2,479 139
Bad debt expense 33 43
Deferred income tax benefit (78) (77)
Loss on sale of marketable securities 10 0
Amortization of premium paid on marketable securities 131 0
Change in the fair value of warrant liability (392) 0
Changes in assets and liabilities    
Accounts receivable 655 (139)
Other assets (19) (2,296)
Deferred sales commissions (695) (643)
Accounts payable (2,134) 3,178
Accrued expenses (3,716) (2,979)
Deferred revenue (16) (209)
Operating lease liabilities (464) (347)
Net cash used in operating activities (14,626) (5,091)
Investing activities:    
Purchases of property and equipment (536) (190)
Purchases of marketable securities (1,477) 0
Proceeds from sale of marketable securities 1,515 0
Principal collected on matured marketable securities 242 0
Proceeds from asset acquisition, net of cash paid 0 1,326
Net cash (used in) provided by investing activities (256) 1,136
Financing activities:    
Repayment on loan payable (140) (1,176)
Repayments on finance lease obligations (6) (143)
Net cash used in financing activities (146) (1,319)
Effect of foreign currency translation (97) (21)
Net increase in cash, cash equivalents and restricted cash (15,125) (5,295)
Cash, cash equivalents, and restricted cash beginning of period 47,317 19,566
Cash, cash equivalents, and restricted cash end of period 32,192 14,271
Supplemental disclosure of cash flow information:    
Interest paid 801 897
Income taxes paid 56 29
Supplemental schedule of noncash investing activities:    
Change in unrealized loss on marketable securities 888 0
Additional right-of-use assets 0 2,637
Contingent consideration in asset acquisition 0 5,969
Reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents:    
Cash and cash equivalents 32,092 14,171
Restricted cash, current 100 0
Restricted cash, net of current 0 100
Total cash, cash equivalents and restricted cash $ 32,192 $ 14,271

Source